Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Gleevec/Glivec

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Gleevec/Glivec was produced by Novartis.

India has big plans for healthcare and pharma

India has big plans for healthcare and pharma A number of court cases are proceeding and earlier this year the Indian Supreme Court denied Novartis patent protection for its cancer drug Glivec.

Bayer wins GIST approval for Stivarga in EU

Bayer wins GIST approval for Stivarga in EU Cancer drug can be used after Pfizer’s Sutent and Novartis’ Glivec. ... Patients must have progressed on - or must be intolerant to - prior treatment with Novartis' Glivec (imatinib) and Pfizer's Sutent (sunitinib) and the European Commission

Novartis' vaccine sales decline ahead of GSK transfer

Novartis' vaccine sales decline ahead of GSK transfer for cancers affecting the bone and the start of generic competition to leukaemia therapy Glivec (imatinib). ... The first generic for Glivec is due in the US market in February 2016, although Novartis is hopeful that the oncology portfolio due to be

Novartis pulls EMA application for expanded Tasigna use

Novartis pulls EMA application for expanded Tasigna use molecular response' when treated with the company's Glivec/Gleevec (imatinib).

Niche-busting cancer immunotherapies

Niche-busting cancer immunotherapies Novartis's Glivec represents the first real advance in getting 'under the hood' of cancer at the molecular level. ... By targeting a protein made by a mutated gene, Glivec has allowed chronic myeloid leukaemia (CML) patients to live nearly normal lives

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Cegedim Health Data

Cegedim Health Data provides Real World Data and Evidence services to enable advancements in patient outcomes. With a data history...

Latest intelligence

Personalised medicine: driving a need for greater diversity in clinical trials
Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today....
Congresses and conferences
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...